Clinical data from a cohort of 155 patients from the International Consortium of AHC were carefully examined, and a distinct genotype-phenotype association study was performed.28 Interestingly, 85% of patients had ATP1A3 mutations, indicating that a small subset fulfilled AHC criteria without any molecular genetic diagnosis. Here, ATP1A3 is linked to alternating hemiplegia of childhood.